Clinical trial
Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease…
NCT00227188 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00227188 |
|---|---|
| Title | Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain. |
| Official title | Effectiveness of Prevnar in the Prevention on IPD in the Paediatric Population in Spain |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Invasive Pneumococcal Disease |
| Intervention type | Drug |
| Interventions | Pneumococcal 7-valent conjugate vaccine Prevnar |
| Enrollment | 408 |
| Start date | May 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 27, 2005 |
| Last update posted | Nov 29, 2012 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: